REPOSITORY
Agenzie, enti di riferimento, società scientifiche
- Dipartimento per le politiche antidroga
- EASL, European Association for the Study of the liver
- ECMMDA, European Monitoring Center for Drugs and Drug Addiction
- FeDerSerD Federazione Italiana degli Operatori dei Dipartimenti e dei Servizi delle Dipendenze
- INHSU International Network for Hepatitis in Substance Users
- SIMIT Società Italiana Malattie Infettive e Tropicali
- SIMSPe onlus Società Italiana di Medicina e Sanità Penitenziaria
- SIPaD Società Italiana Patologie da Dipendenza
- The International Society for the Study of Drug Policy
- Osservatorio fumo, droga e alcol Istituto Superiore di sanità
- UNODC United Nations Office on Drugs and Crime
Linee guida di terapia antivirale
- Recommendations for the management of hepatitis C virus infection among people who inject drugs; International Journal of Drug Policy; 2015.
- European Association for the Study of the Liver (EASL): Recommendations on Treatment of Hepatitis C; 2018.
- European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Prevention and control of infectious diseases among people who inject drugs; 2011.
- American Association for the Study of Liver Diseases (AASLD) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C; 2021.
- WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection; 2016.
Linee guida di trattamento delle tossicodipendenze
- American Society of Addiction Medicine (ASAM): National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use; 2015.
- EMCDDA: Guidelines for the treatment of drug dependence: a European perspective; 2011.
Linee guida di riduzione del danno
- Un elenco aggiornato di documenti è disponibile sul sito dell’EMCDDA
- Ministero della Salute: Linee Guida di riduzione del danno; 2000.
Linee guida di prevenzione e controllo malattie infettive
Linee guida screening e test
- EMCDDA Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users; 2010.
- National Hepatitis C Screening Guideline Development Group (GDG). Hepatitis C Screening National Clinical Guideline No. 15.
- Centers for Disease Control and prevention (CDC): Testing Recommendations for Hepatitis C Virus Infection.
- American Association for the Study of Liver Diseases/Infectious Diseases Society of America (AASLD/IDSA) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection; 2019.
- Presidenza del Consiglio dei Ministri – Dipartimento Politiche Antidroga, Ministero della Salute. Nuove Linee di indirizzo per lo screening e la diagnosi delle principali patologie infettive correlate all’uso di sostanze correlate all’uso di sostanze nei Servizi per le Dipendenze; 2017.
Documenti online
- WHO: Global health sector strategy on viral hepatitis 2016 – 2021.
- EMCDDA, Health and social responses to drug problems: a European guide. Lisbon, October 2017.
- EMCDDA: Italy Country Drug Report; 2019.
- EMCDDA: Relazione europea sulla droga; 2018.
- European Liver Patients Association (ELPA). The 2016 Hep-CORE Report: Monitoring the implementation of hepatitis B and C policy recommendations in Europe.
- Relazione annuale al Parlamento sul fenomeno delle tossicodipendenze in Italia anno 2020 (dati 2019).
- Piano Nazionale per la Prevenzione delle Epatiti Virali da virus B e C (PNEV).
- WHO: Global hepatitis report 2017.
Siti web di riferimento
- World Health Organization – Hepatitis
- Associations collaborating on hepatitis to immunize and eliminate the viruses in Europe (ACHIEVE)
- Correlation – European Network Social Inclusion & Health
- HCV Can Be Cured
- Hepatitis C online
- Hepatitis Clinical Care Options
- European Initiative Hepatitis C and Drug Use (HepC)
- World Hepatitis Alliance
